Abstract: Using PICK1 as an example this review highlights PDZ domains support a repertoire of protein-protein interactions that regulate the subcellular localisation and function of receptors, ion channels and enzymes. PICK1 is a 416 amino acid protein that contains a PDZ domain, a coiled-coil motif/arfaptin homology domain and an acidic c-terminal. Nearly all proteins thus far reported to interact with PICK1 do so via its single PDZ domain. PICK1 self-associates via its coiled-coil motif and together with its PDZ domain has potential to act as a scaffolding protein. This molecule was first identified as a protein interacting with Cα-kinase (PICK1) and interacts with several members of the glutamate receptor family and receptor tyrosine kinases. The PDZ domain of PICK1 has since been shown to interact with a plethora of proteins including dopamine transporter, prolactin-releasing peptide receptor, ion channels BNaC1/ASIC and many more. The single PDZ domain of PICK1 interacts with a network of proteins that is pivotal in processes such as synaptic plasticity, development and neural guidance as well as many diseased states. The proteins that interact with PICK1 and the functional roles of its PDZ domain are discussed and illustrated are ways to regulate PDZ protein-protein interactions.
region of PKCα) [9] . PICK1 (protein interacting with Cα-kinase) was isolated from a T cell cDNA mouse library as a protein interacting with the catalytic domain of PKCα [9] . The type I PDZ binding motif (-QSAV) at the extreme carboxy-terminus (ct) of PKCα interacts with the carboxylate-binding domain (CBD) within the PDZ domain of PICK1 [10] . Exemplified by PICK1, this review describes the role of PDZ domains in protein-protein interactions and underscores how these interactions can be exploited in order to regulate the function of receptors, ion channels and enzymes.
THE PDZ DOMAIN AND STRUCTURE OF PICK1.
PICK1, encoded by 13 exons, is a 416 amino acid protein (rat PICK1) of approximate 50 kDa molecular weight. It expresses widely in many tissues, including heart, lung, muscle, kidney, and the brain where it overlaps with interacting proteins [11, 12] . PICK1 shows high protein sequence conservation through many species and a preserved role through evolution with similar functioning domains, for instance, Caenorhabditis elegans PICK1-like protein also binds PKCα. A number of structural and functional domains occur in PICK of which three regions are of particular interest ( Fig. 1): 
PDZ Domain
The single PDZ domain of PICK1 locates close to its Nterminal and covers approximately the residues 21-105 [9] [10] [11] [13] [14] [15] . The carboxylate binding domain (CBD) of [8] [9] residues occurs in the PDZ domain where Lys 27 and Asp 28 are important amino acids involved in PDZ ligand binding. PICK1 forms clusters when its PDZ domain is truncated or filled by PDZ ligands [14, 15] . An ATP/GTP binding loop (residues [75] [76] [77] [78] [79] [80] [81] [82] with unknown function also resides in the PDZ domain. The PDZ domain of PICK1 is responsible for most of its interactions with other proteins. A summary of proteins families interacting with PICK1 is shown. A representative from each family is given. Type I (S/T-x-Φ), type II (Φ-x-Φ), type III (Ψ-x-Φ) and type IV (D-x-V), where x is any amino acid, Φ and Φ are hydrophobic (V, I, L, A, G, W, C, M, F) and Ψ is basic hydrophilic (H, R, K). Others residues include acidic hydrophilic (D, E) and neutral hydrophilic (N, Q, S, T, Y).
Coiled-coil/AHD/BAR Domain
The central α-helical coiled-coil motif of PICK1, suggested initially to span residues 139-166 [11, 16] , proposes now to be larger in nature covering residues 152-362 with a similar structure to the arfaptin homology domain (AHD) and Bin/amphiphysin/Rvs (BAR) domain [17] [18] [19] [20] . Although the AHD/BAR domain in arfaptin proteins binds ARFs, the PICK1 AHD does not bind ARFs. PICK1 homoligomerises using a site within the PDZ domain and the coiled-coil/BAR motif [10, 13, 21, 22] and these dimers function as docking stations that bring together PICK1 interacting proteins. The colied-coil domain of PICK1 interacts too with soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) and the N-ethylmaleimidesensitive factor (NSF) binding site of GluR2 [23] . Moreover, the PICK1-BAR domain interacts with the linker-II region of GRIP [22] .
Calcium Binding Domains
The glutamate-/aspartate-rich (E/D) acidic region occurs at the C-terminal portion of PICK1 (residues 380-390). E/D rich acidic regions occur in several calcium binding proteins such as calreticulin, calsequestrin and calmodulin where the binding of calcium causes conformational changes and regulates protein interactions. The E/D motif of PICK1 alters PICK1 synaptic localisation and co-clustering of its interacting proteins [13, 21] . PICK1 also has an N-terminal acidic domain that binds calcium and renders PICK1 protein interactions sensitive to calcium levels [23] . Deletion of the N-terminal acidic domain reduces calcium binding to PICK1 and makes PICK1 protein-protein interactions insensitive to calcium levels [23] .
Finally, PICK1 contains a predicted cytoskeletal interaction domain and a number of putative PKC phosphorylation sites (positions 77, 183, 227, 249, 407, rat sequence), tyrosine phosphorylation (residue 275) and casein kinase II (amino acids 82, 379, 412) [24] . PICK1 is phosphorylated by PKCα [9] where the sites and roles of PICK1 phosphorylation require further investigation. To summarize, PICK1 is a scaffold protein, a PKC chaperone and a calcium sensor.
PICK1 TARGETS PKC PHOSPHORYLATION
The two most common posttranslational modifications, phosphorylation and ubiquitination, are usually triggered by an extracellular signal, are rapid and transient in nature reversed by phosphatases and deubiquitinating enzymes respectively [25] [26] [27] . Protein kinase phosphorylation regulates reversibly the function of a large number of proteins and represents an integral part of intracellular signalling involved in cellular function, growth, differentiation and survival [25] . The family of protein kinase C (PKC) enzymes divide into those which are calcium dependent 'classical' (α, βI, βII, γ) and those which are calcium independent 'novel' (δ, ε , θ, µ, η) and 'atypical' (ζ, ι) [25] . The PKC recognition consensus sequence is Ser/Thr-X-Arg/Lys where it phosphorylates serine or threonine residues as compared to the PKA (cAMP-dependent protein kinase) consensus sequence which is Arg/Lys-Arg/Lys-X-Ser/Thr [28] .
The second messenger diacylglycerol activates PKC and is generated by phospholipase C in response to neurotransmitters, hormones or growth factors that bind their G-protein coupled receptors. Phorbol esters TPA (12-Otetradecanoylphorbol-13-acetate) or PMA (phorbol 12-myristate 13-acetate) also activate PKC [29, 30] . Upon a conformational opening (Fig. 2) , PKC translocates to different subcellular sites, generally from cytosolic to membrane, where it phosphorylates and regulates its target proteins [29, 30] . Receptors for activated C-kinase (RACKs) [31] and myristoylated alanine-rich C-kinase substrate (MARCKS) [32] are factors that alter the location and function of kinases [30, 33] . PICK1 is a molecule that plays a key role in PKC phosphorylation and ties PKCα to its targets.
PICK1 is cytoplasmic, localises to the perinuclear region and associates with mitrochondria [9, 14, 15, 34] . TPA activates PKC α and enhances its interaction with PICK1 to induce PICK1-PKC perinuclear clusters [9, 15, 34] (Fig. 2) . The PICK1-PKC clusters are formed by interaction between Fig. (1) . Sequence and domains of PICK1. Top panel shows the species alignment of PICK1. Boxed residues indicate the PDZ domain. PICK1 sequences for various species can be found under the following genebank numbers human NP_036539, rat NP_445912, mouse NP_032863, Drosophila NP_609582 and C. elegans NP_502796. Bottom panel shows a cartoon of the functional domains of PICK1. Fig. (2) . PICK1, PKC and receptor cycling . Simplistic cartoon showing the cycling of PICK1 interacting proteins, based mainly on GluR2-PICK interaction. Receptors, ion channels or transporters are 'anchored' in place by scaffolding proteins (for example GRIP, ABP etc.) either in the plasma membrane or intracellular stores and upon PICK1-directed, PKC-mediated 'phosphorylation' the PICK1 interacting protein is released from the scaffolding protein and is 'free' to be internalised from or inserted into the membrane. the wildtype (but not mutated) PDZ domain of PICK1 and PDZ ligand of PKCα; therefore only an occupied or truncated PDZ-PICK1 forms clusters [15] . In neurons PICK1 occurs in spines and targets activated PKCα toward the synapse where it co-localises and phosphorylates PICK1-interacting proteins often leading to endocytosis [15] .
Wild type PICK1 and a mutated CBD of PICK1 binds mitochondria but PICK1 lacking the whole PDZ domain fails to localise with mitochondria [34] . Serum stimulation (but not TPA) increases perinuclear PICK1 bound to mitochondria and under serum stimulation wild type PKCα but not a deleted PDZ ligand version of PKCα (lacking interaction with PICK1) moves from the cytoplasm to the perinuclear region [34] . Thus PICK1 associates with both mitochondria and PKCα simultaneously where the association of PICK1 with mitochondria and PKCα requires distinct sites. The interaction of PICK1 with mitochondria regulates phosphorlation of resident PKCα substrates such as the anti-apoptotic Bcl-2 or pro-apoptotic Bax [34] .
GLUTAMATE RECEPTORS AND PDZ PROTEINS.

Ionotropic Receptors
Ionotropic glutamate receptors (iGlu-Rs) compose Nmethyl-D-aspartate (NMDA), kainate (KA) and alphaamino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) [35] . iGlu-Rs play a major role in neurological disorders including stroke, pain, epilepsy and schizophrenia. They are involved in excitatory neurotransmission where surface removal and insertion of synaptic receptors regulate neuronal plasticity events such as long-term-potentiation (LTP) anddepression (LTD) [36] [37] [38] [39] [40] [41] . Delineating mechanisms which equilibrate the number of iGlu-Rs on the plasma membrane is principal to understand synaptic strength at glutamateric junctions. iGlu-R removal is a vesicle mediated endocytotic episode similar to that found in the presynaptic terminal; the endocytosis involves clathrin coated vesicles and is also dynamin dependent [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] . The vesicle dependent internalisation and perhaps complete destruction of iGlu-Rs is regulated via ubiquitination, where mono-ubiquitination internalises surface proteins and poly-ubiquitination is a priming event that leads to their degradation via the proteasome [26, 27, 41, 49, 50] . The interactions between PDZ proteins and PDZ motifs of AMPA or KA receptors subunits -GluR1, GluR2 and GluR5 -are summarised below, see Table 2 and Figs. 2-3:
AMPA GluR1
AMPA-Rs compose subunits GluR1-4 and when in complex the GluR1-4 heteromeric AMPA-R associate with a wide range of proteins such as Narp [51, 52] , Stargazin [53] [54] [55] [56] and Lyn [57, 58] which alter AMPA-R synaptic expression, clustering, trafficking and cycling [59] [60] [61] . The ct tails of GluR1 and GluR2 interact with many PDZ domain proteins and these two AMPA-R subunits are the main regulators of AMPA-R cycling and protein coupling [62] .
The ct-GluR1 contains a type I PDZ ligand that interacts with synapse associated protein, SAP97 [59] [60] [61] 63] . The interaction of GluR1 with its PDZ protein partners is a requirement for surface insertion of AMPA-R during CamKII produced synaptic strengthening and LTP [63] . GluR1 additionally interacts with the 4.1G and 4.1N proteins which play a role in AMPA-R trafficking [64, 65] . Via its interaction with Mint1 (also known as X11) GluR1 associates with the CASK_Veli_Mint1 complex, the mammalian homologs of Caenorhabditis elegan LIN2_ LIN7_LIN10 [66] . The CASK_Veli_Mint1 form a complex independent of their PDZ domains which free them to interact with other proteins via their PDZ binding motifs. First, CASK (calcium/calmodulin-dependent serine protein kinase), a membrane-associated guanylate kinase (MAGUK), binds the PDZ motif of neurexin, syndecan and parkin which may link GluR1 to the parkin-dependent ubiquitination complex [27, 49, 50, 66] . Second, Veli binds ct-NR2 (a NMDA receptor subunit) and also the ErbB receptor tyrosine kinases providing possibility for GluR1 to crosstalk with these receptors (see below for ErbB-PICK1 interaction). Finally, Mint binds the kinase molecular motor ct-KIF17, which could 'motor' GluR1 containing AMPA-Rs around the neuron [66] .
AMPA GluR2
AMPA-R complexes that contain an edited form of the GluR2 subunit exhibit low Ca 2+ permeability, giving this subunit particular functional importance [67, 68] . The ctGluR2 is 50 residues in length containing an N-ethylmaleimide-sensitive fusion protein (NSF) proximal binding site [69] [70] [71] which also binds AP2 [72] and an extreme ct type II PDZ binding motif ending with -SVKI. The PDZ ligands of the short splice versions of ct-GluR2, ct-GluR3 and ct-GluR4 interact with a number of PDZ proteins including PICK1, glutamate receptor interacting protein (GRIP), AMPA-R binding protein (ABP) and syntenin [11, 14, [73] [74] [75] [76] [77] . The expression of both PICK1 and GluR2 causes GluR2-PICK1 clusters at perinuclear regions [14] . PICK1 colocalises with AMPA-Rs at excitatory synapses and reduces GluR2 surface expression [11, 14, [78] [79] [80] [81] . GRIP also binds kinesin providing another link for AMPA-Rs to the transport machinery [82, 83] . More than fifty biochemical, cellular and electrophysiological studies published in the past decade collectively indicate that AMPA-Rs cycle rapidly and that interaction with NSF and PDZ proteins (PICK1 and GRIP/ABP) and also PKC-phosphorylation controls synaptic GluR2 receptor cycling. Presented in a simplistic view it appears that NSF inserts and/or stabilises GluR2 into the synaptic membrane, GRIP/ABP anchors GluR2 at the synpase and/or in intracellular stores, and PICK1 promotes PKC phospho-rylation of GluR2 (Ser 880) and releases it from GRIP/ABP anchorage (Fig. 2) . For illustration purposes, the following chain of events depicts one possible scenario of which there are many permeations: (1) activity-dependent entry of Ca 2+ through activated NMDA receptors, (2) Ca 2+ dependent activation of PKCα, (3) PICK1 and PKCα targets GluR2 at excitatory synapses, (4) PKCα phosphorylates GluR2 at Ser-880, in the sequence -SVKI, (5) loss of interaction between phosphorylated GluR2 and GRIP/ABP, but not PICK1, (6) release of GluR2 from membrane anchoring proteins GRIP/ABP, (7) rapid removal of surface GluR2 from the synapse by PICK1, (8) removal of GluR2 and replacement with GluR1 allows AMPA-Rs to permeate Ca 2+ and become functionally more active [11, 14, 15, 19, 22, 23, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [56] [57] [58] [59] [60] [61] [62] [63] .
KA GluR5
The kainate-type ionotropic glutamate receptor subunits GluR5 (2b and 2c) and GluR6 interact with PICK1, GRIP, syntenin and PSD95 [105, 106] . The PDZ binding ligands of GluR5-2b and 2c (-KETVA), GluR6 (-KETMA), but not GluR5-2a (-VEQHY) or GluR7 (-APVFP) are crucial for interaction with the PDZ proteins. The last 20 residues of GluR5-2b interact with PICK1 but not syntenin which needs the last 30 residues of GluR5-2b for interaction [105] . Furthermore, GluR2 and GluR5-2b interact with different affinities with the different PDZ domains of GRIP. PICK1 and GRIP are required for synaptic function of KA-Rs where PICK1 targets PKCα phosphorylation to ct-GluR5-2b at S880 and S886 [105, 107] . A similar type of receptor cycling is also proposed for KA-Rs but in contrast to GluR2, the phosphorylation of GluR5-2b strengthens interaction with GRIP and stabilises KA-Rs at the synaptic membrane. Thus within the same neuron the blockade of PDZ interactions can simultaneously and bi-directionally promote AMPA-R and attenuate KA-R surface expression and synaptic function [105] .
As functional extrapolation of these data the inhibition of GluR2-PDZ and GluR2-NSF interactions have been shown to potentiate and reduce AMPA-evoked release of noradrenaline, respectively, and control noradrenergic neurotransmission [108] . PICK1 partially overlaps with PKCα and GluR2 in somatodendritic regions in components of the rat auditory system. Sound stimulation recruits PICK1 to dendrites of auditory neurons where it may play a role in synaptic transmission and/or plasticity in auditory signalling [109] . GluR2-PICK1 interaction also plays a role in pain, where cell-permeable blocking peptides, based on the GluR2 PDZ motif, regulate neuropathic pain sensitisation [110] . Moreover, KA-Rs and AMPA-Rs are thought to be involved in epilepsy where regulation by PICK1 could play an important role; blocking NSF-GluR2 interaction may too have protective effect against AMPA-R dependent ischemia (and possibly epilepsy) [111] . These observations illustrate that iGluR-PDZ protein-protein interactions are important in normal physiology and in disease.
Metabotropic Receptors
The Group III G-protein-coupled metabotropic glutamate receptor subtype 7a (mGluR7a), a presynaptic autoreceptor, distributes widely throughout the CNS and inhibits glutamate release. The ct-mGluR7 contains three distinct protein interaction and functional domains, namely, a proximal domain involved in intracellular signalling events such as G-protein βγ-subunit coupling, Ca 2+ -calmodulin interaction and PKC phosphorylation [112] [113] [114] [115] [116] [117] [118] ; a central domain involved in axonal targeting [119] ; and an extreme PDZ-binding motif that interacts with PICK1, GRIP and syntenin [13, 16, 21, 24, 77, [117] [118] [119] . PICK1 also interacts with mGluR3, 8a, 8b, 4a and 7b, GRIP interacts with mGluR3, 4a, 6 and 7a whereas syntenin interacts with mGluR4a, 6, 7a and 7b [16, 77, 120] . Furthermore, ctmGluR7b (but not ct-mGluR7a) binds the catalytic γ-subunit of protein phosphatase 1C (PP1γ1 and PP1γ2 but not PP1α1 and PP1β) where binding of PP1C does not compete with PICK1 or syntenin [121, 122] . Such interactions may assemble a complex composed of mGluR7b, PP1C, PICK1 and syntenin [122] . The ct-mGluR7 also associates with Filamin-A [123] and alpha-Tubulin [124] , see Table 2 and Fig. 4.   Fig. (4) . Proteins interacting with mGluR7. P/Q Ca2+, P/Q Ca2+ channels.
Three functional domains and/or roles for the PICK1-mGluR7 interaction are presented: firstly, PICK1 and mGluR7 co-cluster in heterologous cells and overlap at excitatory synapses in hippocampal neurons. Synaptic aggregation and receptor co-clustering but not trafficking of mGluR7 requires both interaction with the PDZ domain of PICK1 and oligomerisation of PICK1 via the coiled-coil motif [13] . The acidic region of PICK1 inhibits mGluR7 aggregation and deletion of the acidic region enhances PICK1 synaptic aggregation and mGluR7 clustering [13] . Secondly, the binding of PICK1 to ct-mGluR7 sterically hinders ct-mGluR7 interaction with G-protein βγ-subunits, Ca 2+ -calmodulin and PKC. The kinases PKC, PKA and PKG (cGMP-dependent protein kinase) phosphorylate mGluR7 at Ser(862) and inhibit calmodulin (CaM) binding to ctmGluR7. Both PICK1 and mutation of Ser(862) regulates phosphorylation of mGluR7 [117, 125] . Thirdly, antisense directed against PICK1, shows that mGluR7-mediated inhibition of P/Q-type Ca 2+ channels requires PICK1 and PKCα phosphorylation [117, 118, 126, 127] . The mGluR7-mediated inhibition of P/Q-type Ca 2+ channels reduces Ca 2+ entry, inhibits presynaptic glutamate release and reduces synaptic transmission [126, 127] .
The mGluR7 null mice have reduced seizure-threshold [128] and develop late-onset epilepsy at 10-12 weeks of age. While no differences are observed in LTP, there is a reduction in short-term potentiation [129] . The mGluR7 null mice experience problems in two separate forms of amygdala-dependent learning and memory behaviours; both fear response and conditioned taste aversion with no obvious changes in locomotor activity or sensation of pain [130] . The mGluR7 -/-mice also show abnormal behaviour in tests associated with depression and anxiety where modulators of mGluR7 may prove useful in regulating these psychiatric disorders [131] . Regulating mGluR7 via its interaction with PICK1 may represent a novel way to develop activitydependent treatment for mGluR7 associated depression and anxiety.
RECEPTOR TYROSINE KINASES AND PICK1.
PTB Binding Motifs
The superfamily of receptor tyrosine kinases (RTKs) constitutes a diverse range of growth factor receptors. Apart from PDZ motifs, the intracellular domains of several RTKs also possess the endocytic code, φX G / N PXY (P) (where φ hydrophobic, X any residue and (P) phosphorylated Tyr). NPxY endocytic motifs are involved in clathrin mediated endocytosis and bind phosphotyrosine interaction/binding domains (PID/PTB). PTB domains were first identified in the Shc adaptor molecule and like PDZ domains occur in several proteins. The binding of an RTK ligand to its receptor causes dimerization which leads to tyrosine kinase auto-phosphorylation of the NPxY motif. Once phosphorylated the NPxY motif (also called SH2 ligand) binds to the Src homology 2 (SH2) domains of Shc and Grb2. Grb2 in turn binds Sos and acts on Ras as a GDP/GTP exchange factor to activate the pathways of extracellularsignal regulated kinase (ERK), c-JUN NH2-terminal kinase (JNK) and cdk5 [132, 133] . The ERK signaling pathway represents a set of sequential phosphorylation events that begins with the Ras activation of a mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK, Raf-1 and B-Raf) which phosphorylates MAP kinase kinase (MAPKK, MEK) and finally activates MAP kinase (MAPK), for example either p44 MAPK (ERK1) or p42 MAPK (ERK2). The activation of ERK regulates gene expression, ion channels and protein synthesis. Tyrosine phosphorylation also recruits the tyrosine phosphatase Shp2 which negatively regulates the signaling pathway, see Table 3 and Fig. 5 . 
Neuregulin Receptors
The neuregulin (NRG) ErbB receptor tyrosine kinases are overexpressed in a number of breast, lung and kidney cancers [132, 134] . These receptors compose four members named epidermal growth factor (EGF), ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4 [132] . The ErbB-R ligands NRG 1-4 of which contain epidermal growth factor (EGF)-like domains and bind ErbB-Rs which induce receptor dimerization, tyrosine kinase activation and finally phosphorylation of many substrates including ErbB-Rs themselves.
The ct located PDZ motifs of ErbB2/HER2, ErbB4/ HER4 and MUSK bind the PDZ domain of PICK1 which regulates surface expression, clustering and activation of ErbB-Rs [135] [136] [137] . ErbB2/HER2 also interacts with the PDZ domain of ERBIN (ERBB2-interacting protein) [135, 136, 138] while ErbB4/HER4 interacts with PSD-95, SAP97 and SAP102 [137, 139, 140] . Interestingly, the Caenorhabditis elegans homolog of ErbB-R (LET23) binds the PDZ domain of LIN7 and so associates with the LIN2/CASK_LIN7/Veli_LIN10/Mint complex [141, 142] . Furthermore the EGF receptor ligand, transforming growth factor α (TGFα), contains a PDZ binding motif and interacts with the PDZ domains of GRIP1 and syntenin [75, 143, 144] .
ErbB-R, AMPA-Rs and mGluR5 are found in astroglial cells of the hypothalamus and are involved in secretion of the neuropeptide luteinising hormone releasing hormone (LHRH) [145] . Release of glutamate from neurons causes AMPA-R and mGluR dependent activation of ErbB-Rs in astroglia which allows LHRH neurons to signal astroglial [145] . The ErbB-R-PICK1 and GluR2-PICK1 (and mGluR5-Homer) interactions may hence play a role in development linked to hypothalamic neuroendocrine neurons [145] . ErbBRs and PDZ proteins also localise at the neuromuscular junction where the interaction of ErbB4-R with PSD-95, SAP97 and Sap102 or interaction of ErbB2-R with Erbin and PICK1 may anchor ErbB-Rs at the synapse and regulate signaling pathways [137] . Finally, the ErbB2/HER2 receptor is overexpressed in cancer where the role of PICK1 warrants investigation [132, 134] .
Eph Receptors and Ephrin Ligands
Ephrin ligands and Eph-Rs play important roles in cellto-cell contact, cell migration, synaptic function, axon guidance and development [147, 148] . The Eph family of RTKs are the largest known with at least 14 Eph-R members and eight "ephrin" ligands [146] [147] [148] [149] . The Eph-R and their ephrin ligands divide into two classes: ephrin-A subclass (ephrin-A1-5) which are glycosylphosphatidylinositol (GPI) membrane tethered and preferentially bind EphA-R subclass (EphA-R 1-8) and the ephrin-B subclass (ephrin-B1-3) which are transmembrane and preferentially bind EphB-R subclass (EphB-R 1-6) [146, 147] .
EphB2-R interacts with PICK1 and GRIP (PDZ domains 6-7), EphA7-R interacts with syntenin and the ephrin ligands interact with PICK1 [75, 150] . Eph-Rs have also been shown to bind the PDZ protein AF6 [151, 152] . The interaction between Eph-Rs and PICK1 (but not GRIP) results in tyrosine phosphorylation of PICK1, although the effect of PICK1 phosphorylation remains indistinct. Coexpression of PICK1 with Eph-Rs or ephrin ligands regulates PKC phosphorylation of presynaptic ephrinB ligands which clusters and induce activation of postsynaptic EphB-R on adjacent cells [150, 151, 153, 154] . The interaction between ephrinB ligands and GRIP allows for "reverse" signalling that links ephrinB ligands to intracellular signalling pathways [77, 149] , see Table 3 and Fig. 5 .
Via clustering and phosphorylation of NMDA-Rs, the EphB2-R plays a role in synaptic function and plasticity [153, [155] [156] [157] [158] . Ephrin-induced oligomerization of EphB2-R, where EphB2-R kinase activity is not needed, causes the extracellular domain of EphB2-R to interact with the NR1 subunit of NMDA receptors at excitatory synapses [157] . In vivo, mice lacking EphB2-R have decreased levels of synaptic NR1 and defects in LTD and LTP; again the kinase domain of EphB2-R is not required [155, 156] . The intimate roles PICK1 plays in Ephrin ligand and Eph-R clustering, activation and signalling may associate PICK1 with events such modulating synaptic morphology, learning and memory, aging and even neurological disorders such as mental retardation [159] .
SYNAPTIC PROTEINS INTERACTING WITH PICK1
Monoamine Transporters
Distruption in monoamine neurotransmission causes several psychiatric, neurologic, and neurodegenerative disorders including depression, obsessive-compulsive behavior, attention deficit, hyperactivity, schizophrenia and Parkinson's disease [160, 161] . Monoamine transporters for dopamine (DAT), norepinephrine (NET) and serotonin (SERT) locate at perisynaptic sites and recycle dopamine (DA), noradrenaline (NA) and 5-hydroxytryptamine (serotonin, 5HT) via uptake and vesicle storage, respectively [160, 161] . In knockout mice, the intracellular stores and transmitter release are both attenuated [162] [163] [164] . Drugs like amphetamine and cocaine stimulate and inhibit these transporters, respectively [161, 165] . The ct ligand of DAT (-LKV) and NET (-LAI), but less so SERT (-NAV) and not the glycine transporter GLYT (-SRI) interact with the PDZ domain of PICK1 [165] [166] [167] . In dopaminergic neurons PICK1 colocalizes with DAT and coexpression of PICK1 results in DAT-PICK1 clusters which enhances DAT uptake activity through an increase in the number of plasma membrane DAT, most likely via a PKC dependent mechanism. Deletion of the PDZ ligand of DAT -LKV (618-620) abolishes its association with PICK1 and impairs DAT surface expression [160, 165] . The residues -RHW (615-617) are also suggested to be important in DAT surface targeting [166] . The changes of DAT surface expression is regulated via PICK1-DAT interaction and represents a novel means by which to alter monoamine transporter function in disease.
BNaC1 Receptor
Neuronal members of the cation degenerin/epithelial Na + ion channel (DEG/ENaC) family include the acid-sensing ion channel (ASIC), the mammalian brain Na + channel 1 (BNaC1), and dorsal-root acid-sensing ion channel (DRASIC). These ion channels have sequence similarity to nematode proteins and are modulated by neuropeptides, acidic pH (extracellular protons). They are involved in mechanotransduction, nociception (pain), synaptic plasticity and regulate sensitivity to cerebral ischemia and acidosis [168, 169] . PICK1 binds the PDZ ligands of BNaC1 (ASIC2a) and BNaC2 (ASIC1a) but not the related proteins ASIC4, DRASIC, αENaC or βENaC [170] [171] [172] . PICK1 and BNaC1α colocalise at peripheral mechanosensory endings of dorsal root ganglion (DRG) neurons and in dendrites and cell bodies of cortical pyramidal neurons, CA3 region of hippocampus and cerebellar Purkinje neurons. Coexpression of PICK1 and BNaC1 clusters both proteins in a punctate manner and regulates the synaptic distribution of BNaC/ ASIC channels in both peripheral and central neurons [170] [171] [172] . ASIC channels have two transmembrane domains with both nt and ct domains inside the cell where PKC phosphorylates Thr-39 on nt-ASIC2a and PKA phosphorylates Ser-479 of ct-ASIC2a [169, 173] . The PKC activator (OAG) increases the amplitude of ASIC2a currents where PICK1 enhances the effects of OAG [173] . Distinctively PKA phosphorylation also regulates PICK1 interaction, in contrast to PKC, the PKA-mediated phosphorylation attenuates PICK1-ASIC1 interaction and controls ASIC1 cellular distribution [169] . Functionally, serotonin enhances PKC via G-protein coupled receptors and promotes ASIC channel currents via a PKC-PICK1-ASIC2b interaction which results in a pH shift and increase of sensory neuron excitability. As a consequence of the PICK1-GluR2 and PICK1-ASIC interactions PICK1 may be linked to and have a role in pain [110, 172] .
PrRP Receptor
The prolactin-releasing peptide receptor (PrRP-R) originally identified as the orphan G protein-coupled receptor (GPC10) binds the endogenous ligand PrRP and releases prolactin from pituitary cells [174] [175] [176] . PrRP-R activation releases the hypothalamic hormones, thought to play a role in food intake [177] [178] [179] [180] [181] . The ct sequence of PrRP-R (-SVVI, type II) interacts with PICK1, GRIP (PDZ 4-5) and ABP but not PSD-95 [182] . Interaction between PrRP-R and GRIP is competitively inhibited by GluR2 and co-expression of PrRP-R with PICK1 forms intracellular clusters [182] . With a valine replacing the lysine, PrRP-R lacks the critical basic residue at -1 position (-SVVI versus -SVKI) for PKC to phosphorylate the preceding serine [182] . In agreement with this, and unlike interaction with GluR2 or GluR5, the GRIP-PrRP interaction is special in that it is not regulated by PKC phosphorylation. Furthermore, okadaic acid an inhibitor of PP1 and PP2A protein phosphatases reduces GRIP interaction indicating the involvement of kinases other than PKC; perhaps PKA similar to the PICK1-ASIC1 interaction [182] . Since a clear functional role for PrRP-R in the CNS remains unclear, it is difficult to predict the role of PDZ proteins interacting with PrRP. PICK1 controls the release of hormone LHRH via its interaction with ErbB receptors [145] and by altering surface expression of PrRP-R may play a further role in hormone release.
UNC5H Receptor
The Netrin-1 ligand attracts migrating neurons and axons that express the 'attractive receptor' Deleted in Colorectal Cancer (DCC). The same Netrin-1 repels neurons and axons that express the 'repulsive receptor complex' DCC and UNC5H, which is a the vertebrate homolog to C. elegans UNC-5. As a result the surface expression of UNC5H controls neuronal and axonal guidance by Netrin-1. PICK1 interacts with the PDZ motif of UNC5H and clusters these proteins in heterologous cells. A PICK1/PKC-dependent mechanism removes UNC5H, but not DCC, from the surface of neurons and growth cones to inhibit the Netrin-1 evoked collapse of hippocampal growth cones [183] . Accordingly, by regulating the surface expression of the UNC5H coreceptor, PICK1 plays a role in neuronal growth via its interaction with the PDZ motif of UNC5H.
Coxsackie and Adenovirus Receptor
The coxsackie and adenovirus receptor (CA-R) binds adenovirus to the cell and helps in viral infection. This CA receptor is not a neuronal synaptic protein but is a receptor that maintains the junction adhesion complex in polarised epithelia. Its expression is reduced in a number of cancers where overexpression of CA-R reduces cell growth [184] . The PDZ motif of CA-R (-GSIV) interacts with PICK1 and other PDZ domain proteins [184] . Deletion of the PDZ motif of CA-R has no effects on viral infection but fails to regulate transepithelial resistance in polarised epithelia and to regulate cellular growth [184] . The effects of PICK1 on CA-R surface expression, epithelial function and cancer deserves further investigation.
Neuroligin 'Receptors'
Neuroligins (Nlg 1 an Nlg 2) are a postsynaptic cell surface trans-synaptic adhesion molecules and a 'receptors' for beta-neurexin that align the postsynaptic membrane with the presynaptic active zone [185] . Rat Neuroligin is 843 residues in length and contains a type I PDZ motif (-TTRV) that binds a slew of PDZ domain proteins including PICK1 and PSD95 but not GRIP or syntenin [185] . Although the role of PICK1-Neuroligin interaction has not been studied it is conceivable that PICK1 alters turnover and trafficking of neuroligins and regulates pre-and post-synaptic strength [185] .
Aquaporin and anion-Exhangers
Aquaporin-9 and Anion exchanger-1 regulate cell volume, pH and ionic balance. The PDZ binding motifs of Aquaporin-9 (-SVIM, type II) and Anion exchanger-1 (-AMPV, type II) have been shown to interact with PICK1 [186] . These proteins are thought to be linked to EphB2 receptors via PICK1 where they may regulate the effects of EphB2 on axonal guidance. Aquaporin and Anion exchangers may also be involved in sound stimulation where PICK1 could play a role together with its interaction with GluR2 [109] .
SIGNALING PATHWAYS LINKED TO PICK1
SNAP-NSF, Syntenin and GRIP
Crosstalk between NSF and PDZ domains occurs via SNAP which tethers the coiled-coil (residues 105-379) region of PICK1 [19, 70, 92, 93] . This region of PICK1 also interacts with the NSF binding site of GluR2 [19] . GluR2, PICK1, NSF, and α-/β-SNAPs form a large mole-cular complex in the presence of ATPγS, where NSF-GluR2 interaction is sensitive to ATP hydrolysis and is enhanced in the presence of PICK1. Like SNARE complex disassembly, NSF ATPase activity inhibits PICK1-GluR2 interactions [19] . Via its ability to tie both NSF and PICK1, the SNAP molecule transfers ATP-hydrolysis-energy from NSF to PICK1 and causes a conformational change that disrupts PICK1-GluR2 interactions. Functionally, the overexpression of SNAP disrupts GluR2-PICK1 interactions and changes AMPA-R trafficking indicating that stabilization of AMPARs by NSF involves GluR2-PICK1 interactions in hippocampal neurons [19] . Inhibitors of synaptotagmin-SNAP receptor SNARE-mediated-exocytosis or peptides that inhibit PICK1/GRIP-AMPA-R interactions attenuate inositol 1,4,5-tris-phosphate receptor (IP3-R)-mediated release of Ca2 + from intracellular stores and these inhibitors increase amplitudes of excitatory postsynaptic current (EPSC) [102] . Moreover, the PICK1-BAR domain interacts with its own PDZ domain and with the linkerII region of GRIP. Binding of GluR2 to the PDZ domain of PICK1 reduces BAR-PDZ self-association of PICK1 and promotes binding of PICK1-BAR to GRIP. Block of the PICK1-GRIP interaction weakens PKC phosphorylation of GluR2 (S880) and controls GluR2 surface cycling [22] . Finally, PICK1 also directly interacts with the type II PDZ ligand of syntenin -IPEV [122] providing yet another means for crosstalk between these range of PDZ domain containing proteins.
Kalirin-7
The Rho subfamily of Ras-like small GTPases (GTP binding proteins) including RhoA, Rac1 and Cdc42 regulate the actin cytoskeleton and events such as spine morphology, receptor trafficking and synaptic plasticity [187] . Proteins that activate Rho-like small GTP binding proteins (GDP/ GTP guanine nucleotide exchange factors, GEFs) possess an oncoprotein Dbl catalytic homology domain (DHD). The catalytic activity of the DHD of Kalirin-7, a brain expressed Dbl member of Rho-GEF and a human ortholog of Duo (a Huntington-associated protein-1 interacting protein), converts the Rac1 bound GDP to GTP and thereby activates Rac1 [188] . Overexpression of Rac1 and Kalirin-7 changes spine-like structures via the DHD and GEF activity of Kalirin-7 and the Rac1 effector p21-activated kinase PAK [187] [188] [189] [190] [191] [192] . The PDZ binding motif (-STYV) of the Kalirin-7 interacts with the PDZ domain of PICK1, PSD95, SAP97, SAP102, AF-6, Mint1 and syntenin, where PICK1 regulates the synaptic targeting of Kalirin-7 and most likely regulates synapse morphology [187] [188] [189] [190] [191] [192] . EphrinB activation of EphB2-Rs induces syndecan-2 and Kalirin-7 phosphorylation and synaptic recruitment; this pathway involves PICK1 and links EphB2-Rs to the actin system that regulates spine structure, morphogenesis and axonal growth [149, 158, 190, 193, 194] .
TIS21/BTG2
The inducible gene product TIS21/BTG2 (mouse homologue tetradecanoyl phorbol ester-induced primary response sequence; human homologue B-cell translocation gene 2) is an immediate-early gene with a protein structure containing 158 residues [195] . TIS21 expression is induced by a number of ligands that activate the PKC pathway such as TPA/PMA, various growth factors (including EGF) and cell stress [196] [197] [198] [199] [200] . In accordance with immediate-early genes, the message and protein levels of TIS21 accumulate and fall rapidly [197, 201] . TIS21 appears to play an early role in mitogenic responses, cell differentiation, cell stress and death. It belongs to the antiproliferative gene family and its overexpression halts cell growth [202] . Interestingly, a non-classical interaction occurs between the PDZ domain of PICK1 and an internal binding motif located at nt-TIS21 [203] . The nt and ct domains of TIS21 mask its interaction site (probably residues 50-68 of TIS21) and under certain conditions the site is uncovered for interaction with PICK1. TIS21 contains many PKC phosphorylation sites and is a better substrate than PICK1 for PKC phosphorylation. Similar to mGluR7 [117, 118] , in vitro phosphorylation studies show that PICK1 reduces PKC-mediated phosphorylation of TIS21 but TIS21 does not alter the phosphorylation of PICK1 [203] . Hypothetically, PICK1 may regulate TIS21-mediated effects on cell growth and the TIS21-PICK1 interaction may play a role in cancer development, similar to ErbB2-PICK1 and/or CAR-PICK1 interactions.
ADP-Ribosylation Factor
ADP-ribosylation factors (ARFs) are cofactors for ADPribosylation of the trimeric Gs protein and also activate phospholipase D (PLD) [204] [205] [206] . Arfaptin proteins 1 and 2 contain arfaptin homology domains (AHD) and bind ARFs [18, 207, 208] . The crystal structure of arfaptin and an amphiphysin protein called BAR (Bin/amphiphysin/Rvs) show each monomer of a coiled-coil motif forms a dimer, creating a crescent-like shape [18, 20] . Whether a similar structure for a PICK1 coiled-coil dimer exists is presently undetermined. PICK1's arfaptin homology domain (residues 244-327 of human PICK1) lacks interaction with ARFs and instead the PDZ domain of PICK1 binds the PDZ motif of ARFs [17] . PICK1 interacts with constitutively active GTPbound, but not GDP-bound, class I ARFs (ARF1, Asn-GlnLys and ARF3, Asn-Lys-Lys) but not the class II ARF5 (Ser-Lys-Arg) and class III ARF6 (Tyr-Lys-Ser) [17, 209, 210] . Class I ARFs locate in the Golgi apparatus and are involved in vesicle formation in the Golgi where PICK1 may play a role [17, 34, 211, 212] . The PDZ protein Tamalin (also known as GRIP-associated scaffold protein, GRASP) associates with mGluR1/5 and also the GEF for ARFs know as cytohesin-2 [213] . Cytohesin-2 supports the activation of ARFs from inactive GDP-bound to active GTP-bound states. Tamalin regulates the trafficking of mGluR1/5 and via a mGluR1/5-Tamalin-Cytohesin-2 complex allows coupling of mGulR1/5 to the ARF signalling cascades [213] . Based on analogy, PICK1 could link its interacting proteins to an alternative intracellular signalling cascade that involves ARFs.
Serine Racemase
PICK1 interacts with glutamate receptors and dopamine transporters -two neurotansmister systems that have been implicated in the pathophysiology of schizophrenia [160, 165, [214] [215] [216] . The region frequently linked to schizophrenia finds the gene coding for pick1 located at chromosome 22q13.1. [216] [217] [218] . Remarkably, a PICK1 rs3952 single nucleotide polymorphism is found in schizophrenics as described in a case study using 225 schizophrenic and 260 control Han Chinese patients [217] . Using 200 schizophrenic and 200 normal control Japanese patients an independent study confirms these findings and shows that the pick1 gene contains SNPs rs3952 [217] and rs2076369 in introns 3 and 4, respectively which associate with schizophrenics [218] . Both SNPs occur in the PDZ domain of PICK1 where they may alter the protein interaction properties of PICK1. In a third study, the occipital cortex of elderly schizophrenia patients (36 patients) but not matched normal controls (26 patients) show an increase of the mRNA of AMPA-R subunits and GRIP with no difference of PICK1 mRNA [216] . Thus, schizophrenic brains may have altered AMPARs and PDZ molecular systems where the PICK1 SNPs are more critical than total PICK1 mRNA levels. Finally, the PDZ domain and the coiled-coil motif of PICK1 has recently been shown to interact with the PDZ binding motif of serine racemase. GRIP also interacts with serine racemase. This enzyme converts L-serine to D-serine, an endogenous ligand for the glycine site of NMDA receptors [219, 220] . Treatment of schizophrenics with D-serine ameliorates some symptoms [219] and genes coding for the D-serine degrading enzyme, D-amino acid oxidase, and its regulator G72 are associated with schizophrenia [220] . These findings are consistent with a role for PICK1 as susceptibility gene for pathogenesis of schizophrenia [218] .
BLOCKING PEPTIDES AND DRUGS THAT INHIBIT PDZ INTERACTIONS Peptides Blocking PDZ Interactions
PDZ domains can accommodate different PDZ motifs where single residue point mutations and phosphorylation (by PKC or Src kinases) of PDZ motifs can regulate selectively interaction with different PDZ domains. A huge amount of emerging data proves that PDZ interactions require very short motifs (3 critical residues) for interaction and reveals that protein interactions which utilise small interaction sites can be readily modulated by synthetic blocking peptides. Blocking peptides based on the PDZ binding motif (for example GluR2; NVYGIESVKI) fit into the PDZ domain and inhibit competitively the interaction between different PDZ binding motifs and PDZ domains (see Table 4 for blocking peptides). These approaches and principles are probably not limited to PDZ interactions and can be used to inhibit many other protein-protein interactions that occurs over short peptide sequences, for example blocking peptides for NSF-GluR2 and PTB-NPxY interactions. For this reason, blocking peptides have potential to control a vast array of protein-protein interactions and regulate cellular function, for further details see Dev 2004 [221] .
As shown with PICK1, PDZ proteins are involved in a slew of interactions where the specificity of blocking PDZ interactions may occur at spatial and temporal levels [12, 76, 78] . PDZ interactions may also differ in their interaction affinities giving another opportunity for differential regulation [105, 222] . The ability to create molecules that specifically modulate these interactions may yield activity dependent blockers [62, 101] . Currently delivery approaches for peptides are somewhat limiting and include injection into the cell via by patch pipette [48] , delivery by virus based systems [111] , complexing synthetic peptides/proteins to carrier molecules [223] , or creating fusion proteins that deliver peptides/protein into the cell [223] [224] [225] .
In an elegant example, a single intravenous bolus injection of a NMDA-PSD95 blocking peptide has been shown to protect against ischemic brain damage [225] . More recently, cell-permeable peptides that block GluR2-protein interactions (PICK1, GRIP and NSF) have been suggested to have potential as novel therapeutics against neuropathic pain [110] . Although degradation and pharmacokinetics of these peptides are not known, the blockade of interactions by small peptides provides promise that PDZ interactions can be developed as novel drug targets and that these interactions can be modulated by drugs.
Drugs blocking PDZ protein interactions
Since every aspect of a cells life cycle and function is driven by protein interactions, the ability to modulate these processes is of great importance not only for understanding cell physiology but also for developing novel treatments against disease [226] [227] [228] . Swapping blocking peptides for small molecular weight compounds therefore represents a crucial step in order to exploit PDZ protein interactions as drug targets. Small molecular weight compounds that bind to a critical interaction site ('hotspot') may be sufficient for modulating protein interactions that utilise small binding sites or those interactions that occur over large surface areas [226, 229] . PDZ domain-motif interaction 'hotspots' may accordingly represent good sites for binding small molecular weight ligands [226] .
In the persuit to replace blocking peptides with chemical drugs a large diversity of compound libraries will undoubtbly increase our chances to identify small molecular weight compounds that block protein-protein interactions. Information on the crystal structure of PDZ domains occupied with PDZ ligands will also help in identification of critical residues involved in protein-protein interactions [5, 15, 18, 167, 226, 230] . Accounts of chemical building blocks, templates and early drug-like hits will too aid in rational drug design. Since only three residues of the PDZ binding motif makes up the majority of interaction with the PDZ domain (the 'hotspot') a predictive pharmacophore model is not unreasonable and may permit the search for peptidomimectics.
It is also important to note that filling PDZ domains with competitive ligands is not the only way to regulate PDZ interactions. Allosteric modulation may provide alternative opportunities to block PDZ interactions where compound binding could alter the conformation of the PDZ domain or the PDZ motif and thus prevent interaction. Recently, small molecule inhibitors of PDZ domains have been described giving evidence that drug-like molecules can be created to inhibit PDZ interactions [231] . High throughput screening of compound libraries will help identify further molecules which block PDZ type protein-protein interactions.
CLOSING REMARKS
The solitary PDZ domain of PICK1 has an amazing ability to interact with a diverse nature of PDZ binding motifs found at the extreme ct regions of receptors, ion channels, transporters and enzymes. It is likely that other proteins will be discovered that interact with PICK1. So far, in most cases PICK1 regulates the surface expression and clustering of membrane-targeted interacting proteins; be that either receptors (GluRs, RTKs and PrRP) ion channel (DEG/ENaC) or transporters (DAT and NET). Via proteinprotein interactions, PICK1 also forms a molecular link to various intracellular signalling systems (Kalirin-7, TIS21 and ARFs). The effects of PICK1 are achieved via the coiled-coil motif that forms PICK1-PICK1 scafolds and by the PICK1-PKC interaction which regulates PKC-mediated phosphorylation. Mechanisms that in turn regulate PICK1 include BDNF which controls PICK1 expression [232] and GTP and Ca2+/calmodulin which alter PICK1 phosphorylation [233] . The regulation of PICK1 expression and phosphorylation may help to control the function of PICK1. More promising is to regulate PICK1 PDZ interactions by blocking peptides and small molecular weight inhibitors. The next challenge that waits is to develope inhibitors that function in vivo and likewise to study the role of PICK1 in disease -interactions with ErbB-Rs, TIS and CA-R warrants the study of PICK1 in cancer and moreover interactions with Glu-Rs, DAT and serine racemase merits the study of PICK1 in schizophrenia. 
ABBREVIATIONS
